427 A phase 1b/2 study of cabozantinib in combination with pembrolizumab in advanced melanoma

• Mohammed Milhem,
• Yousef Zakharia,
• Jayanshu Jain,
• Melanie Frees,
• Hesham Yasin,
• Jaime Bonner,
• Michele Freesmeier,
• Rohan Garje,
• Vyshak Alva Venur

Affiliations

Mohammed Milhem

Aff10 grid.214572.70000000419368294University of Iowa Iowa City IA USA

Yousef Zakharia

Medical Oncology, University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa, USA

Jayanshu Jain

University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Melanie Frees

University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Hesham Yasin

University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Jaime Bonner

University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Michele Freesmeier

University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Rohan Garje

University of Iowa Hospitals and Clinics, Iowa City, IA, USA

Vyshak Alva Venur

University of Iowa Hospitals and Clinics, Iowa City, IA, USA